Patient-derived primary culture cells, consisting of abundant cancer stem cells expressing CD133 and SOX2, were acquired and analyzed (Figure 6(a)), and the effects of treatment with carmustine (BCNU) or (Z)-BP, in the presence/absence of TMZ, were evaluated (Figure 6(b)). Here, SOX2 is linked to cancer.